Millions Miss Out on Antibiotics in Echo of Vaccine Inequity

Efforts to widen access to antibiotics and reduce the threat of superbugs are running into the same problems that have kept Covid vaccines out of reach in many lower-income nations, a report shows.

Only a third of vital antibiotics and antifungals have strategies or licensing agreements to expand their availability, according to the Access to Medicine Foundation, based in Amsterdam. That’s limiting supplies in regions where the risk of drug-resistant infections is highest.